Envestnet Asset Management
AERI

Envestnet Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Envestnet Asset Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-78,879
Closed -$592K – 4087
2022
Q2 		$592K Buy
78,879
+35,423
+82% +$250K ﹤0.01% 2969
2022
Q1 		$395K Buy
43,456
+5,988
+16% +$46.2K ﹤0.01% 3269
2021
Q4 		$263K Sell
37,468
-45,292
-55% -$474K ﹤0.01% 3490
2021
Q3 		$943K Buy
82,760
+16,423
+25% +$240K ﹤0.01% 2589
2021
Q2 		$1.06M Sell
66,337
-4,102
-6% -$70.4K ﹤0.01% 2487
2021
Q1 		$1.26M Buy
70,439
+7,461
+12% +$129K ﹤0.01% 2229
2020
Q4 		$851K Buy
62,978
+8,723
+16% +$105K ﹤0.01% 2327
2020
Q3 		$639K Buy
54,255
+24,790
+84% +$302K ﹤0.01% 2332
2020
Q2 		$435K Buy
29,465
+15,673
+114% +$232K ﹤0.01% 2490
2020
Q1 		$186K Buy
13,792
+4,416
+47% +$83.8K ﹤0.01% 2753
2019
Q4 		$227K Buy
+9,376
New +$194K ﹤0.01% 2871
2017
Q3 		– Sell
-414
Closed -$22K – 3081
2017
Q2 		$22K Hold
414
– – ﹤0.01% 2583
2017
Q1 		$19K Hold
414
– – ﹤0.01% 2678
2016
Q4 		$16K Buy
+414
New +$15.7K ﹤0.01% 2702

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management's AERI Position: Q3 2022 in Review

Envestnet Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 78,879 shares — an estimated $592K sold.

Envestnet Asset Management first reported a position in AERI in Q4 2016 and held it in 14 quarters. The position peaked at $1.26M in Q1 2021. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Envestnet Asset Management reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 78,879 Aerie Pharmaceuticals shares in Q3 2022, an estimated $592K.
  • Envestnet Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2016 and held it in 14 quarters.
  • Envestnet Asset Management's Aerie Pharmaceuticals position peaked at $1.26M in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.